Human melanoma cytolysis by combined inhibition of mTOR and VEGF/VEGFR-2

類似資料

• Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin
  著者:: Slingluff Craig L, 等
  出版事項: (2005-10-01)
• Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin
  著者:: Molhoek, Kerrington R, 等
  出版事項: (2005)
• VEGFR-2 Expression in Human Melanoma: Revised Assessment
  著者:: Molhoek, Kerrington R., 等
  出版事項: (2011)
• Interface of Signal Transduction Inhibition and Immunotherapy in Melanoma
  著者:: Shada, Amber L., 等
  出版事項: (2010)
• Comprehensive analysis of RTK activation in human melanomas reveals autocrine signaling through IGF-1R
  著者:: Molhoek, Kerrington R., 等
  出版事項: (2011)